Search Results 891-900 of 17739 for corticosteroid

  1. A Study of STRO-001 in Patients with Advanced B-Cell Malignancies - Mayo Clinic

    Ongoing immunosuppressive therapy, including systemic corticosteroids. Note: Subjects may be using topical or inhaled corticosteroids. Clinically ...

  2. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

    Treatment with a stable oral corticosteroid dose of ≤ 15 mg prednisone/day ... Treatment with topical (rectal) corticosteroids; e.g., budesonide ≤2 weeks prior ...

  3. Mayo Clinic's Cystic Fibrosis Foundation-designated CF care center

    Short courses of systemic corticosteroids also have been utilized in the treatment of acute exacerbations, in a manner similar to the treatment of those ...

  4. A Study of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection - Mayo Clinic

    Participation eligibility · Exception: eye drop-containing and infrequent inhaled corticosteroids are permissible. Topical corticosteroids are permissible at ...

  5. Cromolyn (nasal route) - Mayo Clinic

    Description. Cromolyn nasal solution is used to help prevent or treat the symptoms (sneezing, wheezing, runny nose, itching) of seasonal (short-term) or ...

  6. Low-Dose Selinexor and Choline Salicylate for the Treatment of Patients With Non-Hodgkin Lymphoma or Histiocytic/Dendritic Cell Neoplasms - Mayo Clinic

    ... corticosteroids (any dose) may continue therapy up until the new regimen has started at investigator discretion. After the start of protocol therapy ...

  7. A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer - Mayo Clinic

    ... corticosteroid treatment or receiving low-dose corticosteroid treatment less than or equal to (≤) 10 milligrams per day (mg/day) prednisone or equivalent.

  8. Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease - Mayo Clinic

    Inadequate response to aminosalicylates, corticosteroids, immunomodulators or biologic therapy. Exclusion Criteria. Diagnosis of ulcerative colitis or ...

  9. A Study to Evaluate the Effectiveness and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - Mayo Clinic

    Participants must have recovered from all radiation-related toxicities, not require corticosteroids, and not have had radiation pneumonitis. Evidence of ...

  10. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

    ... corticosteroids, calcineurin inhibitors, tars, antibiotic creams, topical antihistamines). Note: Corticosteroid inhalers and intranasal sprays are allowed ...